This appointment cathryn worked with Pfizer for 13 years, market cap is 15 times sarepta
does pfizer play in rare disease space? Or is this a very strategic shot across the bow to sarepta to partner with a decent deal cause we are also talking to the big boys?
could spend $300k on this appointment and extract another $50 million out of a deal
Potentiql outstanding roi
This appointment cathryn worked with Pfizer for 13 years, market...
-
- There are more pages in this discussion • 73 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $72.12M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 40738 | 8.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.2¢ | 94978 | 1 |
View Market Depth
| Last trade - 07.28am 02/07/2024 (20 minute delay) ? |
| PER (ASX) Chart |
Day chart unavailable